Page last updated: 2024-09-04

25-hydroxyprotopanaxadiol and Cirrhosis

25-hydroxyprotopanaxadiol has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cui, X; Li, X; Liu, LP; Piao, HR; Xing, DL; Zhang, QG; Zhao, YQ; Zhou, S1

Other Studies

1 other study(ies) available for 25-hydroxyprotopanaxadiol and Cirrhosis

ArticleYear
The novel ginsenoside AD2 prevents angiotensin II-induced connexin 40 and connexin 43 dysregulation by activating AMP kinase signaling in perfused beating rat atria.
    Chemico-biological interactions, 2021, Apr-25, Volume: 339

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Connexin 43; Connexins; Down-Regulation; Fibrosis; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta1; Up-Regulation

2021